Zynex Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 2/6
Zynex has been growing earnings at an average annual rate of 3.5%, while the Medical Equipment industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 27% per year. Zynex's return on equity is 13.5%, and it has net margins of 2.5%.
Wichtige Informationen
3.5%
Wachstumsrate der Gewinne
3.8%
EPS-Wachstumsrate
| Medical Equipment Wachstum der Industrie | 8.9% |
| Wachstumsrate der Einnahmen | 27.0% |
| Eigenkapitalrendite | 13.5% |
| Netto-Marge | 2.5% |
| Letzte Ertragsaktualisierung | 30 Sep 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Zynex (NASDAQ:ZYXI) Seems To Use Debt Quite Sensibly
Oct 26
Zynex, Inc.: 2025 Looks Like A Brighter Year
Oct 09With Zynex, Inc. (NASDAQ:ZYXI) It Looks Like You'll Get What You Pay For
Jul 31Earnings Update: Here's Why Analysts Just Lifted Their Zynex, Inc. (NASDAQ:ZYXI) Price Target To US$19.88
May 03Earnings Miss: Zynex, Inc. Missed EPS By 33% And Analysts Are Revising Their Forecasts
Mar 03Why Investors Shouldn't Be Surprised By Zynex, Inc.'s (NASDAQ:ZYXI) P/E
Jan 24Is Zynex (NASDAQ:ZYXI) Using Too Much Debt?
Aug 03Are Investors Undervaluing Zynex, Inc. (NASDAQ:ZYXI) By 43%?
Mar 30Should You Be Adding Zynex (NASDAQ:ZYXI) To Your Watchlist Today?
Jan 23Short Squeeze Candidate With Low PEG Ratio: Zynex
Oct 05Zynex begins enrollment in blood loss detection trial for CM-1600 monitoring system
Sep 21These 4 Measures Indicate That Zynex (NASDAQ:ZYXI) Is Using Debt Safely
Aug 02Zynex Cures The Pain Of Its Shareholders: Q2 Results
Aug 01Zynex: Upside Looks Well Priced In, Efficiency Headwinds Remain
Jul 25Is Zynex, Inc. (NASDAQ:ZYXI) Trading At A 46% Discount?
Jul 12Zynex June and Q2 orders hit all-time high, re-affirms Q2 and FY22 guidance
Jul 11Aufschlüsselung der Einnahmen und Ausgaben
Wie Zynex Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 30 Sep 24 | 194 | 5 | 145 | 0 |
| 30 Jun 24 | 194 | 6 | 144 | 0 |
| 31 Mar 24 | 189 | 8 | 140 | 0 |
| 31 Dec 23 | 184 | 10 | 136 | 0 |
| 30 Sep 23 | 186 | 16 | 130 | 0 |
| 30 Jun 23 | 177 | 17 | 122 | 0 |
| 31 Mar 23 | 169 | 17 | 114 | 0 |
| 31 Dec 22 | 158 | 17 | 104 | 0 |
| 30 Sep 22 | 150 | 18 | 96 | 0 |
| 30 Jun 22 | 143 | 20 | 89 | 0 |
| 31 Mar 22 | 137 | 19 | 84 | 0 |
| 31 Dec 21 | 130 | 17 | 81 | 0 |
| 30 Sep 21 | 116 | 10 | 77 | 0 |
| 30 Jun 21 | 101 | 5 | 72 | 0 |
| 31 Mar 21 | 89 | 5 | 63 | 0 |
| 31 Dec 20 | 80 | 9 | 53 | 0 |
| 30 Sep 20 | 69 | 10 | 43 | 0 |
| 30 Jun 20 | 60 | 11 | 35 | 0 |
| 31 Mar 20 | 52 | 10 | 30 | 0 |
| 31 Dec 19 | 45 | 9 | 26 | 0 |
| 30 Sep 19 | 41 | 9 | 23 | 0 |
| 30 Jun 19 | 37 | 10 | 19 | 0 |
| 31 Mar 19 | 34 | 10 | 17 | 0 |
| 31 Dec 18 | 32 | 10 | 16 | 0 |
| 30 Sep 18 | 31 | 10 | 14 | 0 |
| 30 Jun 18 | 29 | 10 | 13 | 0 |
| 31 Mar 18 | 27 | 9 | 11 | 0 |
| 31 Dec 17 | 23 | 7 | 10 | 0 |
| 30 Sep 17 | 18 | 4 | 8 | 0 |
| 30 Jun 17 | 15 | 3 | 8 | 0 |
| 31 Mar 17 | 13 | 1 | 8 | 0 |
| 31 Dec 16 | 13 | 0 | 9 | 0 |
| 30 Sep 16 | 13 | -1 | 10 | 0 |
| 30 Jun 16 | 12 | -2 | 10 | 0 |
| 31 Mar 16 | 12 | -2 | 9 | 0 |
| 31 Dec 15 | 12 | -3 | 9 | 0 |
| 30 Sep 15 | 11 | -1 | 9 | 0 |
| 30 Jun 15 | 13 | -1 | 10 | 0 |
| 31 Mar 15 | 11 | -6 | 11 | 0 |
| 31 Dec 14 | 11 | -6 | 11 | 0 |
| 30 Sep 14 | 12 | -11 | 13 | 0 |
| 30 Jun 14 | 13 | -12 | 15 | 0 |
| 31 Mar 14 | 17 | -8 | 21 | 0 |
| 31 Dec 13 | 22 | -7 | 21 | 0 |
Qualität der Erträge: ZYXI has high quality earnings.
Wachsende Gewinnspanne: ZYXI's current net profit margins (2.5%) are lower than last year (8.6%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: ZYXI's earnings have grown by 3.5% per year over the past 5 years.
Beschleunigtes Wachstum: ZYXI's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Erträge im Vergleich zur Industrie: ZYXI had negative earnings growth (-69.8%) over the past year, making it difficult to compare to the Medical Equipment industry average (11.7%).
Eigenkapitalrendite
Hohe Eigenkapitalrendite: ZYXI's Return on Equity (13.5%) is considered low.